AA
ALR

AlphaMark Advisors’s AlerisLife Inc ALR Stock Holding History

AlphaMark Advisors’s Portfolio ALR Stock Details ALR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-126
Closed -$1K – 576
2020
Q3 		$1K Sell
126
-173
-58% -$824 ﹤0.01% 528
2020
Q2 		$1K Sell
299
-260
-47% -$927 ﹤0.01% 528
2020
Q1 		$2K Buy
+559
New +$2.35K ﹤0.01% 488

Other funds holding ALR

VCM
V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TG
TCW Group Los Angeles, California $14.9B AUM 46.29% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $333M AUM 102.25% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
FP
Foundry Partners Minneapolis, Minnesota $1.89B AUM 9.84% 1-Year Est. Return

AlphaMark Advisors's ALR Position: Q4 2020 in Review

AlphaMark Advisors sold out of AlerisLife Inc (ALR) in Q4 2020, closing a stake of 126 shares — an estimated $1K sold.

AlphaMark Advisors first reported a position in ALR in Q1 2020 and held it in 3 quarters. The position peaked at $2K in Q1 2020. 106 funds tracked by Wall St. Rank hold ALR as of Q4 2020.

  • AlphaMark Advisors reported no remaining AlerisLife Inc position as of Q4 2020 after selling out during the quarter.
  • AlphaMark Advisors sold 126 AlerisLife Inc shares in Q4 2020, an estimated $1K.
  • AlphaMark Advisors first reported a position in AlerisLife Inc in Q1 2020 and held it in 3 quarters.
  • AlphaMark Advisors's AlerisLife Inc position peaked at $2K in Q1 2020.
  • 106 funds tracked by Wall St. Rank held AlerisLife Inc as of Q4 2020.

Based on AlphaMark Advisors's 13F filing for Q4 2020, filed 1 Feb 2021.